Performance in fiscal 2018
In UnitedHealth Group’s (UNH) fourth-quarter earnings release, the company announced its fiscal 2018 revenues of $226.2 billion—a rise of 12% YoY (year-over-year). The company’s Optum business emerged as a major growth driver and clocked more than $101.3 billion in revenues in fiscal 2018—a rise of 11.07% YoY.
UnitedHealth Group reported earnings from operations of $17.3 billion in fiscal 2018—a rise of 14% YoY. According to the press release, the company’s Optum business reported higher-than-projected earnings in fiscal 2018. The UnitedHealthcare business reported earnings in line with the projections made during the November Investor Conference
UnitedHealth Group has reported a net EPS of $12.19 in fiscal 2018—a rise of 13.71% YoY. The company expects its fiscal 2019 net EPS to fall by $13.70–$14.00.
In the fourth quarter, UnitedHealth Group reported revenues of $58.4 billion—a rise of 12.09% YoY and a sequential rise of 3.18%. The company reported earnings from operations of $4.5 billion in the fourth quarter—a rise of 12.50% YoY and a sequential decline of 2.17%. UnitedHealth Group reported a net EPS of $3.10 in the fourth quarter—a decline of 15.07% YoY.
On January 15, analysts’ 12-month consensus recommendation for UnitedHealth Group is a “buy.” The company’s 12-month consensus target price is $305.74, which is 23.25% higher than its closing price on January 14. The highest target price estimate for the company is $335, while the lowest target price estimate is $269.
Among the 25 analysts covering UnitedHealth Group on January 15, 11 recommend a “strong buy,” 13 recommend a “buy,” and one recommends a “hold.”